Last Update 06 Mar 26

Fair value Decreased 21%

CDLX: Reset Expectations And CFO Return Will Support Future Rerating

Analysts have trimmed their Cardlytics price target from $1.50 to $1.25, reflecting updated assumptions around fair value, revenue trends, and profitability following recent guidance resets and business changes.

Analyst Commentary

Recent commentary around the reduced US$1.25 price target centers on how quickly Cardlytics can adjust to its updated outlook and business mix after the Q1 guidance reset, the BofA exit, and the Bridg divestiture.

Bullish Takeaways

Bullish analysts see the Q1 guidance reset as a way to align expectations more closely with current conditions, which can reduce the risk of future guidance surprises.
The lower target is viewed by some as reflecting a more conservative fair value framework, which they see as better calibrated to near term revenue and profitability assumptions.
By acknowledging the impact of the BofA exit and Bridg divestiture upfront, bullish analysts view the story as cleaner, with fewer moving parts to factor into their valuation work.
Some investors may interpret the comment that the bar is now level set as a sign that execution against this reset bar could be easier to track and evaluate over the next few quarters.

Bearish Takeaways

Bearish analysts focus on the reduced target as a reminder that recent guidance has required adjustment, which raises questions about visibility into revenue and earnings.
The reference to shares being in show me territory highlights caution around execution risk, with a view that Cardlytics needs to deliver consistent results before sentiment can improve.
Concerns remain that the combined effect of the BofA exit and the Bridg divestiture may limit growth optionality relative to prior expectations, which can weigh on valuation frameworks.
Some cautious investors may see the US$1.25 target as reflecting limited room for error, where any further reset to assumptions could pressure fair value estimates again.

What's in the News

Cardlytics appointed David Evans as Chief Financial Officer, effective January 12, 2026. This marks his return to the company after previously serving in multiple executive roles, including CFO and Chief Administrative Officer from 2014 to 2020 (Key Developments).
Evans previously supported Cardlytics through its earlier years as a public company, including its IPO in 2018. More recently he has been an advisor and board member across several software and technology businesses, including his current role as Board Chair at Neighborly Software in Atlanta (Key Developments).
The CFO transition follows the planned departure of Alexis DeSieno, who will step down from her officer role and remain in a non-officer advisory capacity until March 6, 2026, to support continuity and a smoother handover (Key Developments).

Valuation Changes

Fair Value: Reduced from $1.63 to $1.29, a moderate cut that aligns with the new $1.25 price target.
Discount Rate: Adjusted slightly higher from 12.32% to 12.33%, a minimal change in the risk input.
Revenue Growth: Updated from a 10.35% decline to an 8.32% decline, indicating a somewhat less negative revenue outlook in the model.
Net Profit Margin: Trimmed from 10.13% to 10.02%, a small reduction in long term profitability assumptions.
Future P/E: Lowered from 7.23x to 6.38x, pointing to a more conservative earnings multiple being used in the updated valuation work.

4 views

Key Takeaways

Expansion into diverse partnerships and innovative platforms increases user engagement and positions the company for sustainable revenue growth and operational scale.
Enhanced data privacy compliance and advanced analytics strengthen advertiser loyalty, create pricing power, and boost recurring, high-margin revenue streams.
Content restrictions by a major partner, platform competition, advertiser churn, slow innovation, and reliance on debt all heighten financial and operational risks for Cardlytics.

Catalysts

About Cardlytics

Operates an advertising platform in the United States and the United Kingdom.What are the underlying business or industry changes driving this perspective?

Rapid expansion and diversification of partnerships-with new financial institutions and the launch of the Cardlytics Rewards platform targeting non-bank publishers-position the company to access a broader and more engaged user base, directly supporting future revenue growth and operating leverage as these partners ramp.
Increasing adoption of personalized, data-driven marketing by top-tier brands and vertical-focused go-to-market strategies enhance advertiser stickiness and spend; this trend is reinforced by Cardlytics' improved analytics capabilities and engagement-based pricing, which should drive higher net margins and recurring billings over time.
Growing regulatory focus on consumer privacy is making first-party, consent-based purchase data (which Cardlytics uniquely provides through its bank relationships) more valuable to advertisers, creating long-term pricing power and defensibility that can support net income growth as ad budgets shift from non-consented platforms.
Strategic investment in AI-driven analytics, enhanced customer insights portals, and self-serve dashboards is increasing advertiser ROI and accelerating sales cycles, which is likely to boost contribution margins and operational efficiency, supporting improved overall earnings.
The accelerating success and adoption of new offerings (e.g., Rippl and Bridg CPG), as evidenced by recent high-profile partnerships and rapid billings growth in the U.K., opens incremental high-margin revenue streams and mitigates concentration risk, setting the stage for multi-year top-line and EBITDA expansion.

Cardlytics Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

Analysts are assuming Cardlytics's revenue will decrease by 10.3% annually over the next 3 years.
Analysts are not forecasting that Cardlytics will become profitable in next 3 years. To represent the Analyst Price Target as a Future PE Valuation we will estimate Cardlytics's profit margin will increase from -68.9% to the average US Media industry of 10.1% in 3 years.
If Cardlytics's profit margin were to converge on the industry average, you could expect earnings to reach $19.4 million (and earnings per share of $0.32) by about September 2028, up from $-183.3 million today. The analysts are largely in agreement about this estimate.
In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 7.2x on those 2028 earnings, up from -0.3x today. This future PE is lower than the current PE for the US Media industry at 20.8x.
Analysts expect the number of shares outstanding to grow by 4.75% per year for the next 3 years.
To value all of this in today's terms, we will use a discount rate of 12.32%, as per the Simply Wall St company report.

Cardlytics Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?

The sudden and material content restrictions imposed by Cardlytics' largest financial institution (FI) partner significantly reduce available inventory and campaign reach for many brands, leading to an immediate and ongoing decrease in billings and revenue, as well as heightening risks of further partner-driven platform instability in the future (impacts: revenue, earnings).
Pricing pressure and declining monetization efficiency (evidenced by a 15% year-over-year decline in ACPU and lower revenue-to-billings margin) reflect diminished negotiating leverage and intensifying platform competition, challenging Cardlytics' long-term ability to sustain net margins and earnings.
Weakness and churn among mid
and small-sized U.S. advertisers, combined with ongoing softness in key verticals like travel and restaurants, point to macroeconomic and category-specific risks that may constrain overall demand for Cardlytics' core offering and pressure top-line revenue growth.
Strategic prioritization and slower pace of investment in analytics, AI, and new products-due to financial headwinds and the need for operational retrenchment-raise concerns over Cardlytics' ability to innovate and maintain long-term competitive differentiation, threatening future revenue diversification and earnings growth.
Reliance on debt financing to manage near-term liquidity and repay maturing notes, at a time of contracting cash flow and reduced free cash flow, indicates elevated financial risk and may further constrain the company's ability to absorb shocks, invest in growth, or withstand prolonged downturns (impacts: cash flow, potential dilution, long-term earnings).

Valuation

How have all the factors above been brought together to estimate a fair value?

The analysts have a consensus price target of $1.625 for Cardlytics based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $2.0, and the most bearish reporting a price target of just $1.5.
In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $191.8 million, earnings will come to $19.4 million, and it would be trading on a PE ratio of 7.2x, assuming you use a discount rate of 12.3%.
Given the current share price of $0.89, the analyst price target of $1.62 is 45.2% higher.
We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Cardlytics?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Bank Partnerships And Data-Driven Marketing Will Shape Future Markets